CAR-T Therapy Versus Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: Systematic Review and Metanalysis of Toxicity and Response

被引：0
|
作者：
Mehta, Mansi [1 ]
Namjoshi, Devang [1 ]
Fernandes, Bolivia Crocete Aloysia [2 ,3 ]
Mukhtiar, Vaibhavi [1 ]
Bhanushali, Charmi [1 ]
Kumar, Madhan Srinivasan [4 ]
Rana, Gunjan [1 ]
Santhi, Jaison Lawrence Alexander [5 ]
Mishra, Tanisha [6 ]
Ramanathan, Muthalagu [7 ,8 ]
机构：
[1] St Vincent Hosp, Worcester, MA, Brazil
[2] St Marys Gen Hosp, New York Med Coll, Grad Med Educ Program, Denville, NJ USA
[3] St Clares Hlth, Denville, NJ USA
[4] St Vincent Hosp, Internal Med, Worcester, MA, Brazil
[5] Mercy Catholic Med Ctr, Aldan, PA USA
[6] Manipal Acad Higher Educ, Kasturba Med Coll, Manipal, India
[7] Univ Massachusetts, Mem Med Ctr, Dept Med, Div Hematol Oncol, Worcester, MA, Brazil
[8] UMass Mem Med Ctr, Div Stem Cell Transplantat, Worcester, MA, Brazil
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-206207
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6929 / 6930
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of CAR-T Therapy for Relapse or Refractory Multiple Myeloma: A systematic review and meta-analysis
    Yang, Qin
    Li, Xin
    Zhang, Fangrong
    Yang, Qiaohui
    Zhou, Wen
    Liu, Jing
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (08): : 1786 - 1797
  • [32] APRIL CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Phase I Clinical Trial
    Li, Wenxiao
    Hu, Yongxian
    Zhang, Mingming
    Lai, Xinyi
    Zhao, Mengyu
    Fu, Shan
    Hong, Ruimin
    Chang, Alex H.
    Huang, He
    BLOOD, 2024, 144 : 7229 - 7229
  • [33] Cost per Responder Analysis to Assess the Value of CAR-T Therapy for Relapsed or Refractory Multiple Myeloma
    Martin, Thomas
    Usmani, Saad Z.
    Joseph, Nedra
    Crivera, Concetta
    Valluri, Satish
    Jackson, Carolyn C.
    Cohen, Lucas
    Singh, Sumeet
    Jagannath, Sundar
    BLOOD, 2021, 138
  • [34] BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma
    Yan, Yuhan
    Tu, Yixuan
    Cheng, Qian
    Zhang, Jian
    Wang, Erhua
    Deng, Zuqun
    Yu, Yan
    Wang, Liwen
    Liu, Rui
    Chu, Ling
    Kang, Liqing
    Liu, Jing
    Li, Xin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [35] Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China
    Wu, Weijia
    Ding, Shuyi
    Zhang, Mingming
    Zhou, Yuping
    Sun, Xueshan
    Zhao, Zixuan
    Yang, Yi
    Hu, Yongxian
    Dong, Hengjin
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 701 - 709
  • [36] Efficacy of Bispecific Antibodies Vs CAR-T in the Treatment of Extramedullary Disease and High-Risk Cytogenetics in Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis
    Vegivinti, Charan Thej Reddy
    Santhi, Jaison Lawrence Alexander
    Liu, Lawrence
    Keesari, Praneeth Reddy
    Thakur, Rahul
    Hammami, M. Bakri
    Kapu, Venkatesh
    Pericherla, Sindhu
    Gopireddy, Murali Mohan Reddy
    Poojary, Nagarathna
    Ghimire, Ananta
    Shah, Nishi
    Janakiram, Murali
    BLOOD, 2023, 142
  • [37] CAR T-cell therapy for relapsed or refractory multiple myeloma
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (06): : E297 - E297
  • [38] The CAR-Hematotox Score As a Prognostic Model of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma
    Rejeski, Kai
    Hansen, Doris K.
    Bansal, Radhika
    Sesques, Pierre
    Ailawadhi, Sikander
    Logue, Jennifer M.
    Freeman, Ciara L.
    Alsina, Melissa
    Theurich, Sebastian
    Locke, Frederick L.
    Bachy, Emmanuel
    Jain, Michael D.
    Lin, Yi
    Subklewe, Marion
    BLOOD, 2022, 140 : 7506 - 7508
  • [39] Advances in CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials in the Last Two Years
    Aiman, Wajeeha
    Ali, Muhammad Ashar
    Zubair, Hina
    Butt, Sigmone Khalid
    Anwar, Muhammad Yasir
    Hamza, Mohammad
    Nanjundaiah, Nikhilesh
    Chemarthi, Venkata Sireesha
    Shaaban, Hamid
    Guron, Gunwant
    Maroules, Michael
    Anwer, Faiz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S485 - S486
  • [40] The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
    Rejeski, Kai
    Hansen, Doris K.
    Bansal, Radhika
    Sesques, Pierre
    Ailawadhi, Sikander
    Logue, Jennifer M.
    Braeunlein, Eva
    dos Santos, David M. Cordas M.
    Freeman, Ciara L.
    Alsina, Melissa
    Theurich, Sebastian
    Wang, Yucai
    Krackhardt, Angela M.
    Locke, Frederick L.
    Bachy, Emmanuel
    Jain, Michael D.
    Lin, Yi
    Subklewe, Marion
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
12345